Gustavo Mostoslavsky Selected Research

Gustavo Mostoslavsky Research Topics

Disease

5	COVID-19 02/2022 - 01/2021
5	Neoplasms (Cancer) 01/2020 - 05/2006
4	Infections 01/2022 - 01/2008
2	Sickle Cell Anemia (Hemoglobin S Disease) 11/2017 - 11/2016
2	Aneuploidy (Aneuploid) 10/2014 - 04/2008
2	Inflammation (Inflammations) 08/2007 - 02/2007
1	Breakthrough Infections 01/2022
1	Diarrhea 01/2021
1	Nausea 01/2021
1	Neurocognitive Disorders (Clerambault Syndrome) 12/2020
1	Neuroinflammatory Diseases 12/2020
1	Anastomotic Leak 01/2019
1	Fetal Death 01/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 10/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017
1	Acute Promyelocytic Leukemia 10/2017
1	Insulin Resistance 11/2014
1	Weight Gain 11/2014
1	Down Syndrome (Down's Syndrome) 10/2014
1	Proteostasis Deficiencies 01/2013
1	Transthyretin-Related Hereditary Amyloidosis 01/2013
1	Encephalitis (Encephalitis, Rasmussen) 11/2012
1	Melanoma (Melanoma, Malignant) 03/2012
1	Breast Neoplasms (Breast Cancer) 06/2011
1	Endotoxemia 08/2007
1	Severe combined immunodeficiency with sensitivity to ionizing radiation 10/2006
1	Medulloblastoma 05/2006
1	Genomic Instability 01/2006
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2005
1	Lupus Nephritis 10/2005
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2005
1	Leukemia 06/2005
1	Neointima 10/2004
1	Multiple Myeloma 05/2004

Drug/Important Bio-Agent (IBA)

3	AntibodiesIBA 02/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2008 - 05/2004
2	Viral RNAIBA 01/2021 - 12/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 05/2004
2	ChromatinIBA 01/2018 - 01/2006
2	GlobinsIBA 11/2017 - 11/2016
2	Fetal Hemoglobin (Hemoglobin F)IBA 11/2017 - 11/2016
2	Small Interfering RNA (siRNA)IBA 04/2008 - 08/2007
2	DNA (Deoxyribonucleic Acid)IBA 10/2005 - 06/2005
1	Neutralizing AntibodiesIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	CytokinesIBA 12/2020
1	Biopolymers (Biopolymer)IBA 01/2019
1	IgA receptor (protein B)IBA 10/2017
1	Messenger RNA (mRNA)IBA 10/2017
1	AdipokinesIBA 11/2014
1	LipidsIBA 11/2014
1	Pharmaceutical PreparationsIBA 10/2014
1	Prealbumin (Transthyretin)IBA 01/2013
1	Toll-Like Receptor 3IBA 11/2012
1	Estrogens (Estrogen)FDA Link 06/2011
1	rho GTPase-activating proteinIBA 08/2007
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2007
1	PPAR alphaIBA 02/2007
1	Angiogenesis InhibitorsIBA 02/2007
1	Cyclin D2IBA 05/2006
1	NestinIBA 05/2006
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2006
1	AutoantibodiesIBA 10/2005
1	Laminin (Merosin)IBA 10/2005
1	Peptides (Polypeptides)IBA 10/2005
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2004
1	InterleukinsIBA 05/2004
1	Proto-Oncogene Proteins c-hckIBA 05/2004
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2004
1	Phosphotransferases (Kinase)IBA 05/2004
1	Tyrosine (L-Tyrosine)FDA Link 05/2004
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2004
1	src-Family KinasesIBA 05/2004

Therapy/Procedure

3	Therapeutics 11/2017 - 10/2006
1	Highly Active Antiretroviral Therapy (HAART) 12/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2007
1	Transplantation 10/2006